Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Benefits of Blood Money: OxyContin & Ethics

Philip Seo, MD, MHS  |  Issue: March 2019  |  March 18, 2019

Ethics & Network Television

Steve Heap / shutterstock.com

Steve Heap / shutterstock.com

Recently, I have been watching a television comedy series on NBC called The Good Place, starring Ted Danson and Kristen Bell.

As a general rule, news from the world of television is not a topic discussed in these pages, but if you indulge me for just a little bit longer, I promise this will start to make sense.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The Good Place, somewhat surprisingly, deals with issues surrounding life, death and morality.

In its most recent storyline, it has been tackling the challenges of doing good in a highly interrelated, complex world. Consider the apple, for example. You would think buying an apple from the supermarket would be a morally neutral action. But now consider the pesticides required to ensure an unblemished blush to the skin and the migrant farmworkers who applied that pesticide. And what about that supermarket? Do the stockboys receive health insurance?

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Because our bandwidth is already fully taxed by the issues that smack us in the face, most of us elect to ignore the complexities that lie just beneath the surface. We blithely put the apple into our cart and hope the balance of the universe is not altered too much.

But does deliberate ignorance of the ethical issues leave our hands fully clean?

And so we return to that protest at the Guggenheim. It just so happens that Nan Goldin, the artist, is also Nan Goldin, the addict, who spent a year struggling with her addiction to OxyContin. And at some point during that struggle, Ms. Goldin realized that many of the same museums that displayed her work were supported by the profits generated by the sale of OxyContin. And she wants to make sure you know this, as well.

The Sackler family has a combined estimated worth of $13 billion.18 A good deal of that fortune is spent on philanthropy. Hence, the Sacklers of Purdue Pharma are also the Sacklers of the Metropolitan Museum of Art, the Smithsonian, the Royal Academy in London, the Victoria and Albert Museum, the Louvre, the Tate Modern, the American Museum of Natural History, Princeton, Tufts, Harvard and Yale. And, of course, the Guggenheim. In 2015 alone, the Arthur M. Sackler Foundation donated $1.1 million in art to various institutions.

The medical community has also been the recipient of the Sacklers’ largesse. The Raymond and Beverly Sackler Foundation donated $2 million to Tufts University’s Sackler School of Graduate Biomedical Sciences. The Dr. Mortimer and Theresa Sackler Foundation donated $6 million to New York Presbyterian Hospital.

Does the source of the money really matter, as long as it is being used to do good? Ours is an era of moral reckoning in which we are asked, time and again, to decide whether we can hate an artist but love his art. The deep involvement of the Sackler family and their money in the genesis of the opiate crisis demonstrates that even in this time of moral relativism, some lines should not be crossed. There has to be some point at which the means are not justified by the ends, and all the art wings in the world cannot possibly justify the bodies that lie in the Sacklers’ wake.

Up to this point, blissful ignorance may have justified our blind acceptance of the Sackler family’s munificence. But we are no longer ignorant. The connection between OxyContin and the opioid epidemic is painfully clear. And so we are given a moral obligation to do the one thing the Sackler family desperately wants to prevent. We need to remember. Because until the Sackler foundations partition some of their fortune toward unwinding the damage done in the name of profit, none of us should benefit from 200 deaths a day. 

Page: 1 2 3 4 | Single Page
Share: 

Filed under:EthicsOpinionRheuminationsSpeak Out Rheum Tagged with:Arthur M. Sackler FoundationDr. Mortimer and Theresa Sackler Foundationopioid crisisopioid use disordersOxyContinPurdue PharmaRaymond and Beverly Sackler Foundation

Related Articles

    Carla Guggenheim, DO, Dances through the Pain

    December 18, 2018

    Two years ago, Carla Guggen­heim, DO, a rheumatologist in private practice in Lansing, Mich., was recovering from extensive shoulder surgery when her dance teacher asked her to perform a complex Indian piece from the Bharatanatyam Repertory at a gala showcasing graduate dance students. Because of her surgery, Dr. Guggenheim agreed to dance only 90 seconds…

    On Boulders & Other Projects

    December 18, 2019

    The year is drawing to a close, and I have not been forced to release a statement that I am leaving The Rheumatologist “to spend more time with my family.” Once again, improbably, I have made it to the finish line. Given that, now seems to be a good time to reflect, and to give…

    U.S. Appeals Court Ruling May Clear Barrier to Generic OxyContin

    February 3, 2016

    (Reuters)—A federal appeals court ruled Monday that four patents related to Purdue Pharma’s painkiller OxyContin are invalid, potentially bringing Teva Pharmaceutical Industries Ltd and others a step closer to introducing generic versions of the drug. Privately owned, Connecticut-based Purdue had sued Teva, Amneal Pharmaceuticals and Epic Pharma after they sought approval from the U.S. Food…

    New Jersey Sues OxyContin Maker, Links Marketing to Opioid Crisis

    November 1, 2017

    (Reuters)—New Jersey on Tuesday sued Purdue Pharma LP, accusing the OxyContin maker of contributing to the state’s opioid crisis through deceptive marketing to doctors and patients, including the elderly and the “opioid-naive.” Christopher Porrino, the New Jersey attorney general, faulted what he called a decade-long marketing campaign of “almost inconceivable callousness and irresponsibility, and said…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences